Progress in the development of therapeutic antibodies targeting prion proteins and beta-amyloid peptides.
Prion diseases and Alzheimer's disease (AD) are characterized by protein misfolding, and can lead to dementia. However, prion diseases are infectious and transmissible, while AD is not. The similarities and differences between these diseases have led researchers to perform comparative studies. In the last 2 decades, progress has been made in immunotherapy using anti-prion protein and anti-beta-amyloid antibodies. In this study, we review new ideas and strategies for therapeutic antibodies targeting prion diseases and AD through conformation dependence.
He
JinSheng
J
College of Life Sciences and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China. jshhe@bjtu.edu.cn
Zhang
Ying
Y
Hong
Tao
T
D016229:Amyloid beta-Peptides / Q000276:immunology*; D000906:Antibodies / Q000276:immunology*; D006801:Humans; D011328:Prions / Q000276:immunology*
D016229:Amyloid beta-Peptides; D000906:Antibodies; D011328:Prions